Research Articles Library
Literature Analysis Tools
Advanced Search
Filter by PMID, year, source, DOI and other criteria
Literature Analysis
Analyze research trends and hotspots
Batch Export
Export search results to Excel/PDF
Blastocystis hominis; Friend or Foe
Publication Year: 2024 Source: Integr Med (Encinitas) PMID: 39534663
Blastocystis hominis (B. hominis) remains the most common parasite identified through stool examination. A clinician will undoubtedly encounter the presence of this parasite numerous times in their career. Thus, it is vital to know if this organism is a 'friend or foe', or in other words, whether it is a …
Intestinal Permeability In Subjects With Rheumatoid Arthritis: A Critical Therapeutic Priority
Publication Year: 2024 Source: Integr Med (Encinitas) PMID: 39534664
No Abstract
MnNi@PVP Nanoenzyme Based on Regulating Inflammation and Immune Homeostasis for the Therapy of Inflammatory Bowel Disease
Publication Year: 2024 Source: ACS Appl Mater Interfaces PMID: 39534949
No Abstract
Mechanism of Resveratrol on LPS/ATP-induced pyroptosis and inflammatory response in HT29 cells
Publication Year: 2024 Source: Autoimmunity PMID: 39534992
No Abstract
Differential contributions of the gut microbiota and metabolome to pathomechanisms in ulcerative colitis: an in vitro analysis
Publication Year: 2024 Source: Gut Microbes PMID: 39535140
No Abstract
Real-World Comparative Effectiveness and Safety of Filgotinib and Upadacitinib for Ulcerative Colitis: A Multicentre Cohort Study
Publication Year: 2024 Source: United European Gastroenterol J PMID: 39535492
No Abstract
Correction to: Health-Related Quality of Life Outcomes With Etrasimod Treatment in Patients With Ulcerative Colitis: A Post Hoc Analysis of Data From ELEVATE UC 52 and ELEVATE UC 12
Publication Year: 2024 Source: Inflamm Bowel Dis PMID: 39536025
No Abstract
Participants' perspectives on a multimodal stress management and comprehensive lifestyle modification program for patients with Crohn's disease-A qualitative interview study
Publication Year: 2024 Source: PLoS One PMID: 39536026 DOI: 10.1371/journal.pone.0313127
BACKGROUND: Crohn's disease (CD) is a type of inflammatory bowel disease (IBD) that is prevalent worldwide and associated with reduced quality of life for patients. Multimodal therapy approaches, which emphasize lifestyle modifications such as mindfulness and stress reduction, can be promising in enhancing health-related quality of life for IBD patients. …
Biologics and Oral Small Molecules Are Not Associated With Increased Major Adverse Cardiovascular Events or Venous Thromboembolism in Inflammatory Bowel Disease
Publication Year: 2024 Source: Inflamm Bowel Dis PMID: 39536156 DOI: 10.1093/ibd/izae267
BACKGROUND: Biologics and oral small molecules (OSM) effectively treat inflammatory bowel disease (IBD), but some are linked to higher risks of major adverse cardiovascular events (MACE) and venous thromboembolism (VTE). This study evaluates the MACE and VTE risks in IBD patients treated with biologics or OSM. METHODS: Using the TrinNetX …
The Bidirectional Relationship Between Sleep and Pain in Crohn's Disease: A Daily Diary Study
Publication Year: 2024 Source: Inflamm Bowel Dis PMID: 39536319 DOI: 10.1093/ibd/izae265
BACKGROUND: Pain is common in Crohn's disease (CD) even after endoscopic healing is achieved. Depression, sleep disturbances, fatigue, and worry about pain impact the pain experience. There is a bidirectional relationship between sleep and pain, though it has received minimal attention in CD. Herein, we sought to comprehensively assess this …
Need more literature?
The current database contains 98453 research articles. If you need to search for more literature or perform AI analysis, please use our knowledge acquisition module or explore external literature resources.
External Resources: Access comprehensive literature databases worldwide